SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Exela Technologies, Inc. (XELA) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+636263.6%).
- Analyst consensus target $70.00 (+636263.6% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 33/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — XELA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.41
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$70.00 (+636263.6%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.04 |
$805.23M |
$-371.93K |
-0% |
| 2016 |
$-90.16 |
$789.93M |
$-48.1M |
-6.1% |
| 2017 |
$-24,960.00 |
$1.15B |
$-209.48M |
-18.3% |
| 2018 |
$-14,086.50 |
$1.59B |
$-169.81M |
-10.7% |
| 2019 |
$-419.27 |
$1.56B |
$-509.12M |
-32.6% |
| 2020 |
$-145.31 |
$1.29B |
$-178.53M |
-13.8% |
| 2021 |
$-48.27 |
$1.17B |
$-142.39M |
-12.2% |
| 2022 |
$-13.49 |
$1.08B |
$-415.58M |
-38.6% |
| 2023 |
$-22.37 |
$1.06B |
$-125.16M |
-11.8% |
| 2024 |
$-0.41 |
$142.77M |
$-12.37M |
-8.7% |
